Evidence map›Paper›PMID 39154104›Full record

ArticleScientific reports2024

High prevalence of asymptomatic and subpatent Plasmodium falciparum infections but no histidine-rich protein 2 gene deletion in Bouaké, Côte d'Ivoire.

André Barembaye Sagna, Yilekal Gebre, Claudia Abigail Vera-Arias, Dipomin François Traoré, Bertin N'cho Tchekoi, Serge Brice Assi, Amnan Alphonsine Koffi, Christophe Rogier, Franck Remoue, Cristian Koepfli

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Micronutrient status, food security, anaemia,Frontiers in nutrition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

André Barembaye SagnaMIVEGEC, University of Montpellier, IRD, CNRS, Montpellier, France. andre.sagna@ird.fr.
Yilekal GebreDepartment of Biological Sciences and Eck Institute for Global Health, University of Notre, Dame, Notre Dame, IN, USA.
Claudia Abigail Vera-AriasDepartment of Biological Sciences and Eck Institute for Global Health, University of Notre, Dame, Notre Dame, IN, USA.
Dipomin François TraoréInstitut Pierre Richet, Institut National de la Santé Publique, Bouaké, Côte d'Ivoire.
Bertin N'cho TchekoiInstitut Pierre Richet, Institut National de la Santé Publique, Bouaké, Côte d'Ivoire.
Serge Brice AssiProgramme National de Lutte Contre le Paludisme en Côte d'Ivoire, Ministère de la Santé et de l'Hygiène Publique, Abidjan, Côte d'Ivoire.
Amnan Alphonsine KoffiInstitut Pierre Richet, Institut National de la Santé Publique, Bouaké, Côte d'Ivoire.
Christophe RogierPrimum Vitare, Paris, France.
Franck RemoueMIVEGEC, University of Montpellier, IRD, CNRS, Montpellier, France.
Cristian KoepfliDepartment of Biological Sciences and Eck Institute for Global Health, University of Notre, Dame, Notre Dame, IN, USA. ckoepfli@nd.edu.

Funding

Expertise France 12INI210
6 · The paper itself

Abstract

This study aimed to estimate the prevalence of asymptomatic and subpatent P. falciparum infections in the city of Bouaké, Central Côte d'Ivoire, to compare the performance of three tests, and to investigate potential P. falciparum histidine-rich protein 2 (pfhrp2) gene deletions. A cross-sectional survey was conducted in nine neighborhoods in Bouaké in 2016. Matched light microscopy (LM), rapid diagnostic test (RDT), and quantitative PCR (qPCR) data were used to determine the prevalence of P. falciparum infection and compare the performance of the three diagnostic tests. Pfhrp2/3 deletions were genotyped by digital PCR. Among 2313 individuals, 97.2% were asymptomatic and 2.8% were symptomatic. P. falciparum prevalence among symptomatic individuals was 25.8%, 30.3%, and 40.9% by LM, RDT, and varATS qPCR, respectively, and among asymptomatic individuals, it was 10.3%, 12.5%, and 34.9%. Asymptomatic infections comprised 96.4% of all malaria infections, with 58.2% detectable only by varATS qPCR. Although the prevalence of asymptomatic P. falciparum infections was higher in school-age children (5-14 years: 42.0%) compared to < 5 years (17.3%) and ≥ 15 years (35.9%), subpatent infections were more likely in ≥ 15 years (70.4%) than in < 5 years (39.7%) and school-age children (41.2%). LM and RDTs were reliable only at parasite densities > 10,000 parasites/µL. Individuals who were positive according to all three tests had significantly greater parasite density (856.8 parasites/µL; 95% CI 707.3-1,038) than did those who were positive by varATS qPCR only (13.7 parasites/µL; 95% CI 11.4-16.3) (p < 0.0001). No pfhrp2 deletions were observed. The high prevalence of asymptomatic and subpatent infections highlights the need for targeted strategies to reduce malaria in urban Côte d'Ivoire.

Indexed as

Antigens, ProtozoanAsymptomatic InfectionsGene DeletionMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsAdolescentAdultAgedChildChild, PreschoolCote d'IvoireCross-Sectional StudiesFemaleHumansInfantAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumProtozoan ProteinsAsymptomaticsCôte d’Ivoirepfhrp2/3Plasmodium falciparumSubpatentUrban malaria

Identifiers

PMID39154104
PMCPMC11330520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.